cagrilintide/semaglutide (CagriSema) - Novo Nordisk
CagriSema US sales projection: $2B in 2027 - Dec 10, 2025 - A subscription to AlphaSense is required to access document | REPORT TITLE: "Novo Nordisk "Price declines are tough to offset with volume" (Neutral) Weston" | Author: Matthew Weston, et al | DATE: 12/04/25 
Sales projection Obesity
https://research.alpha-sense.com/
 
Dec 10, 2025
 
If you have access to Aftermarket Research from AlphaSense, please log in to your account and enter title to find the report.